TRAVERE THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
TRAVERE THERAPEUTICS, INC. (TVTX) reported Proceeds from Issuance of Private Placement of $30.90 million for the 12-month period ending 2013-12-31, per its 10-K/A filed 2015-07-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2013-09-30 was $24.92M.
- TRAVERE THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2013-03-31 was $9.95M.
- TRAVERE THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2013 was $30.90M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|
| 2013-12-31 | $30.90M 10-K/A · filed 2015-07-09 | |
| 2013-09-30 | $24.92M 10-Q/A · filed 2015-07-09 | |
| 2013-03-31 | $9.95M 10-Q/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |